NFKB1 and cancer: Sakamoto et al. reported that NF-κB activation was observed in 40% (35 of 88) of colorectal carcinomas, and NF-κB activation was determined by p65 nuclear staining, which was observed in >50% of the cancer cells in the carcinoma tissues [24].